Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Organon & Co. | 77,869 | reported | 12 Nov 2025 | tx 7+145,216.93 |
| electroCore, Inc. | 66,964 | reported | 07 Jun 2019 | tx 5+87,964 |
| CARDINAL HEALTH INC | 41,631 | reported | 09 Nov 2022 | tx 15+41,631 |
| Cartesian Therapeutics, Inc. | 15,629 | reported | 02 Jan 2025 | tx 18+959,821−277,500 |
| ARRAY BIOPHARMA INC | 10,000 | reported | 30 Jul 2019 | tx 10+68,000−68,000 |
| Solventum Corp | 4,848 | reported | 15 May 2026 | tx 8+32,732−11,484 |
| CELGENE CORP /DE/ | 0 | reported | 20 Nov 2019 | tx 56+200,891−252,081 |
| TEXAS INSTRUMENTS INC | 0 | reported | 13 May 2026 | tx 96+326,196.12−285,276 |
| Merck & Co., Inc. | 0 | reported | 03 Nov 2009 | tx 58+3,453,797−4,108,152.22 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | GRANT_AWARD | Solventum Corp | 4,848 | 0.00 USD | deriv |
| 13 May 2026 | EXERCISE | TEXAS INSTRUMENTS INC | 4,306 | 110.15 USD | |
| 13 May 2026 | EXERCISE | TEXAS INSTRUMENTS INC | 4,532 | 104.41 USD | |
| 13 May 2026 | SALE | TEXAS INSTRUMENTS INC | 8,393 | 306.37 USD | |
| 13 May 2026 | SALE | TEXAS INSTRUMENTS INC | 445 | 307.04 USD | |
| 13 May 2026 | EXERCISE | TEXAS INSTRUMENTS INC | 4,306 | 0.00 USD | deriv |
| 13 May 2026 | EXERCISE | TEXAS INSTRUMENTS INC | 4,532 | 0.00 USD | deriv |
| 27 Mar 2026 | EXERCISE | Solventum Corp | 6,336 | 0.00 USD | |
| 27 Mar 2026 | EXERCISE | Solventum Corp | 6,336 | 0.00 USD | deriv |
| 29 Jan 2026 | GRANT_AWARD | TEXAS INSTRUMENTS INC | 525 | 0.00 USD | |
| 29 Jan 2026 | GRANT_AWARD | TEXAS INSTRUMENTS INC | 1,860 | 0.00 USD | deriv |
| 12 Nov 2025 | PURCHASE | Organon & Co. | 65,400 | 7.67 USD | |
| 13 Jun 2025 | GRANT_AWARD | Organon & Co. | 23,904.38 | 10.04 USD | deriv |
| 13 May 2025 | EXERCISE | Solventum Corp | 5,148 | 0.00 USD | |
| 13 May 2025 | EXERCISE | Solventum Corp | 5,148 | 0.00 USD | deriv |
| 14 May 2025 | PURCHASE | Organon & Co. | 12,469 | 8.07 USD | first after silence |
| 30 Apr 2025 | GRANT_AWARD | Solventum Corp | 4,916 | 0.00 USD | deriv |
| 27 Jan 2025 | GRANT_AWARD | TEXAS INSTRUMENTS INC | 614 | 0.00 USD | |
| 27 Jan 2025 | GRANT_AWARD | TEXAS INSTRUMENTS INC | 2,551 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 2,600 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 8,000 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | Organon & Co. | 9,638.55 | 20.75 USD | deriv |
| 13 May 2024 | GRANT_AWARD | Solventum Corp | 6,336 | 0.00 USD | deriv |
| 13 May 2024 | GRANT_AWARD | Solventum Corp | 5,148 | 0.00 USD | deriv |
| 25 Jan 2024 | GRANT_AWARD | TEXAS INSTRUMENTS INC | 686 | 0.00 USD |
5 purchases reported after at least 12 months of silence — most recent on 14 May 2025.